Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?

References

• Guidi AJ, Abu-Jawdeh G, Berse B, . Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;87: 1237–45
   PubMed Web of Science ®Google Scholar
• Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997;76:1410–15
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim HS, Park JT, Lee MC, Park CS. Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status. Anal Quant Cytol Histol 2003;25:303–11
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhang X, Peng Y, Wang Z. The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol Oncol 2005;97:96–103
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer 1999;80:827–33
   PubMed Web of Science ®Google Scholar
• Yasmeen S, Romano PS, Pettinger M, . Incidence of cervical cytological abnormalities with aging in the Women's Health Initiative: a randomized controlled trial. Obstet Gynecol 2006; 108:410–19
   PubMed Web of Science ®Google Scholar
• Sawaya GF, Grady D, Kerlikowske K, . The possible predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med 2000;133:942–50
   PubMed Web of Science ®Google Scholar
• Cummings SR, Ettinger B, Delmas PD, . The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697–708
   PubMed Web of Science ®Google Scholar
• Chung SH, Lambert PF. Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists. Proc Natl Acad Sci USA 2009;106:19467–72
   PubMed Web of Science ®Google Scholar
• Castle PE. Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials. Int J Cancer 2011;128:997–8
   PubMed Web of Science ®Google Scholar
• Sioulas V, Christodoulakos G, Lambrinoudaki I, Politi E, Sergentanis TN, Creatsas G. E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene. Fertil Steril 2008;89:1018–20
   PubMed Web of Science ®Google Scholar
• Αlbrecht ED, Robb VA, Pepe GJ. Regulation of placental vascular endothelial growth factor/permeability factor expression and angiogenesis by estrogen during early baboon pregnancy. J Clin Endocrinol Metab 2004;89:5803–9
   Google Scholar
• Tropea A, Lanzone A, Tiberi F, Romani F, Catino S, Apa R. Estrogens and androgens affect human luteal cell function. Fertil Steril 2010;94:2257–63
   PubMed Web of Science ®Google Scholar
• Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 1993;41:671–8
   PubMed Web of Science ®Google Scholar
• Sun Q, Tsutsumi K, Kelleher MB, Pater A, Pater MM. Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells. Cancer Res 1992;52:4254–60
   PubMed Web of Science ®Google Scholar
• Mirkin S, Mahony MC, Archer DF. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells. Menopause 2004;11:82–8
   PubMed Web of Science ®Google Scholar
• Navarro FJ, Mirkin S, Archer DF. Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells. Fertil Steril 2003;79:1409–15
   PubMed Web of Science ®Google Scholar
• Alvaro D, Mancino MG, Onori P, . Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol 2006;14: 3537–45
   Google Scholar
• Pufe T, Claassen H, Scholz-Ahrens KE, . Influence of estradiol on vascular endothelial growth factor expression in bone: a study in Göttingen miniature pigs and human osteoblasts. Calcif Tissue Int 2007;80:184–91
   PubMed Web of Science ®Google Scholar
• Dabrosin C. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo. Clin Cancer Res 2005;11: 8036–41
   PubMed Web of Science ®Google Scholar
• Okada H, Tsutsumi A, Imai M, Nakajima T, Yasuda K, Kanzaki H. Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells. Fertil Steril 2010;93:2680–6
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. Cancer Lett 1999;141:63–71
   PubMed Web of Science ®Google Scholar
• Lindström AK, Stendahl U, Tot T, Hellberg D. Associations between ten biological tumor markers in squamous cell cervical cancer and serum estradiol, serum progesterone and smoking. Anticancer Res 2007;27:1401–6
   PubMed Web of Science ®Google Scholar
• Mirkin S, Wong BC, Archer DF. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and thrombospondin-1 messenger RNA in breast cancer cells. Int J Gynecol Cancer 2006; 16(Suppl 2):560–3
   PubMedGoogle Scholar
• Nanobashvili J, Prager M, Jozkowicz A, . Positive effect of treatment with synthetic steroid hormone tibolone on intimal hyperplasia and restenosis after experimental endothelial injury of rabbit carotid artery. Eur Surg Res 2004;36: 74–82
   PubMed Web of Science ®Google Scholar
• Cline JM, Register TC, Clarkson TB. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys. Menopause 2002;9:242–52
   PubMed Web of Science ®Google Scholar
• Sauvé F, McBroom LD, Gallant J, Moraitis AN, Labrie F, Giguère V. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol Cell Biol 2001;21:343–53
   PubMed Web of Science ®Google Scholar